US and UK guidelines for glucocorticoid-induced osteoporosis: similarities and differences.
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 6 (1) , 66-69
- https://doi.org/10.1007/s11926-004-0085-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Use of Inhaled Corticosteroids and Risk of FracturesJournal of Bone and Mineral Research, 2001
- Corticosteroid Osteoporosis: Practical Implications of Recent TrialsJournal of Bone and Mineral Research, 2000
- Use of Oral Corticosteroids and Risk of FracturesJournal of Bone and Mineral Research, 2000
- Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid-Induced Osteoporosis in Men and Women: A Randomized TrialJournal of Bone and Mineral Research, 2000
- Use of oral corticosteroids in the United KingdomQJM: An International Journal of Medicine, 2000
- Calcium and vitamin D for corticosteroid‐induced osteoporosisCochrane Database of Systematic Reviews, 1998
- Elimination and Biochemical Responses to Intravenous Alendronate in Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 1997
- Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosisArthritis & Rheumatism, 1996
- A randomized, placebo‐controlled trial of calcium supplementation for decreased bone density in corticosteroid‐using patients with inflammatory bowel disease: a pilot studyAlimentary Pharmacology & Therapeutics, 1996
- Microcrystalline hydroxyapatite compound in prevention of bone loss in corticosteroid-treated patients with chronic active hepatitisPostgraduate Medical Journal, 1985